ArticleBlood cancer journal2022

Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series.

Jennifer L Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.